NEW YORK, June 8, 2020 – DataArt, a global software engineering firm that designs, develops, and supports high-quality solutions, and Financial Strides, a fintech company that specializes in building innovative financial products, today announced a partnership to provide end-to-end solutions for businesses in the financial services industry.
In his guest post in HypeBot, Sergey Bludov, SVP of Media & Entertainment at DataArt, explores how the challenges faced by the music industry as a result of the current crisis have inspired some artists and other industry players to find innovative ways to adapt and thrive.
New York, May 29, 2020 — DataArt, a global software engineering firm that designs, develops, and supports high-quality solutions, today announced that it has been named a BigCommerce Agency Partner, with more than 60,000 BigCommerce customers gaining access to DataArt’s technology development services.
In Brilliance Security Magazine, Dmitry Vyrostkov, Head of Security at DataArt , discusses the key vulnerabilities that DataArt identified in iOS and Android mobile applications during numerous security assessments.
In a bylined article for iGaming Business, Russell Karp, VP of Media and Entertainment at DataArt, looks at the halt of the gambling industry as an opportunity to re-evaluate, enhance and future-proof underlying technology and execute strategic initiatives.
In InsurTech Insights, DataArt’s experts, Denis Baranov and Peter Rakowsky, discuss how insurance companies can benefit from outsourcing.
Standing on the Shoulders of Giants: The Art & Science of Machine Learning & AI for Drug Discovery & Repurposing
In Pharmaboardroom, Daniel Piekarz, SVP Healthcare and Life Sciences at DataArt, explores how machine learning and artificial intelligence can play into drug repurposing, potentially providing solutions to the most pressing healthcare concerns of today, including the COVID-19 pandemic.
In a bylined article for iGaming Business, Russell Karp, VP of Media and Entertainment at DataArt, discusses the hurdles faced by the GB Gambling Commission with its responsible gambling initiative and shares his ideas on possible solutions.
In HCPLive, Daniel Piekarz, SVP of Healthcare & Life Sciences at DataArt, debates whether the COVID-19- related clinical trial standstill will drive the industry towards virtual trials.